Cancer Epidemiology
Volume 33, Issue 5 , Pages 337-346 , November 2009

Incidence of extranodal non-Hodgkin lymphomas among whites, blacks, and Asians/Pacific Islanders in the United States: Anatomic site and histology differences

  • Xiao-Cheng Wu

      Affiliations

    • School of Public Health, Louisiana State University Health Sciences Center, New Orleans, LA, United States
    • Corresponding Author InformationCorresponding author at: LSU School of Public Health/Louisiana Tumor Registry, 1615 Poydras Street. Suite 1400, New Orleans, LA 70112, United States. Tel.: +1 504 568 5763; fax: +1 504 568 5800.
    • ,
  • Patricia Andrews

      Affiliations

    • School of Public Health, Louisiana State University Health Sciences Center, New Orleans, LA, United States
    • ,
  • Vivien W. Chen

      Affiliations

    • School of Public Health, Louisiana State University Health Sciences Center, New Orleans, LA, United States
    • ,
  • Frank D. Groves

      Affiliations

    • Department of Epidemiology and Clinical Investigation Sciences, School of Public Health and Information Sciences, University of Louisville, Louisville, KY, United States

,Accepted 23 September 2009.

References 

  1. American Cancer Society . Cancer facts & figures 2008. Atlanta: American Cancer Society; 2008;
  2. Groves FD, Linet MS, Travis LB, Devesa SS. Cancer surveillance series: non-Hodgkin's lymphoma incidence by histologic subtype in the United States from 1978 through 1995. J Natl Cancer Inst. 2000;92:1240–1251
  3. Hartge P, Wang SS, Bracci PM, Devesa SS, Holly EA. Non-Hodgkin lymphoma. In:  Schottenfeld D,  Fraumeni J editor. Cancer epidemiology and prevention. New York: Oxford; 2006;p. 898–918
  4. Zucca E, Roggero E, Bertoni F, Cavalli F. Primary extranodal non-Hodgkin's lymphomas. Part 1: gastrointestinal, cutaneous and genitourinary lymphomas. Ann Oncol. 1997;8:727–737
  5. Surveillance, Epidemiology and End Results (SEER) Program (www.see.cancer.gov) SEER*Stat Database: Incidence – SEER 9 Regs Limited-Use, Nov 2008 Sub (1973–2006) <Katrina/Rita Population Adjustment> – Linked To County Attributes – Total U.S., 1969–2006 Counties, National Cancer Institute, DCCPS. Surveillance Research Program, Cancer Statistics Branch, released April 2009, based on the November 2008 submission.
  6. Lopez-Guillermo A, Colomo L, Jimenez M, Bosch F, Villamor N, Arenillas L, et al. Diffuse large B-cell lymphoma: clinical and biological characterization and outcome according to the nodal or extranodal primary origin. J Clin Oncol. 2005;23:2797–2804
  7. Jehan Z, Siraj AK, Abubaker J, Ruiz C, Simon R, Sultana M, et al. Distinct gene expression profiles: nodal versus extranodal diffuse large B-cell lymphoma. Oncology. 2008;75:71–80
  8. Ribeiro RC, Fairclough DL, Sandlund JT, Crist WM, Berard CW, Pui CH. Extranodal primary tumor site indicates poor prognosis in childhood head and neck non-Hodgkin's lymphomas. Leukemia. 1991;5:615–620
  9. Weinberg OK, Ma L, Seo K, Beck AH, Pai RK, Morales A, et al. Low stage follicular lymphoma: biologic and clinical characterization according to nodal or extranodal primary origin. Am J Surg Pathol. 2009;33:591–598
  10. AlShemmari SH, Ameen RM, Sajnani KP. Extranodal lymphoma: a comparative study. Hematology. 2008;13:163–169
  11. de Sanjose S, Dickie A, Alvaro T, Romagosa V, Garcia Villanueva M, Domingo-Domenech E, et al. Helicobacter pylori and malignant lymphoma in Spain. Cancer Epidemiol Biomarkers Prev. 2004;13:944–948
  12. Parsonnet J, Hansen S, Rodriguez L, Gelb AB, Warnke RA, Jellum E, et al. Helicobacter pylori infection and gastric lymphoma. N Engl J Med. 1994;330:1267–1271
  13. Catassi C, Bearzi I, Holmes GK. Association of celiac disease and intestinal lymphomas and other cancers. Gastroenterology. 2005;128:S79–S86
  14. Weinstock MA, Gardstein B. Twenty-year trends in the reported incidence of mycosis fungoides and associated mortality. Am J Public Health. 1999;89:1240–1244
  15. In:  Ellison JH,  Wu XC,  McLaughlin CC,  Lake A,  Firth R,  Cormier M, et al. editor. Cancer in North America, 1999–2003. Volume one: incidence.. Springfield, IL: North American Association of Central Cancer Registries, Inc.; May 2006;
  16. Harwell TS, Miller SH, Lemons DL, Helgerson SD, Gohdes D, Harwell TS, et al. Cancer incidence in Montana: rates for American Indians exceed those for whites. Am J Prev Med. 2006;30:493–497
  17. Fritz A, Percy C, Jack A, Shanmugaratnam K, Sobin L, Parkin D. International classification of diseases for oncology. 3rd ed.. Geneva, Switzerland: World Health Organization; 2000;
  18. Ries LAG, Harkins D, Krapcho M, Mariotto A, Miller BA, Feuer EJ, et al., editors. SEER Cancer Statistics Review, 1975–2003. Bethesda, MD: National Cancer Institute. http://seer.cancer.gove/1975_2003/ [Based on November 2005 SEER data submission, posted to the SEER web site, 2006].
  19. Morton LM, Turner JJ, Cerhan JR, Linet MS, Treseler PA, Clarke CA, et al. Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph). Blood. 2007;110:695–708
  20. In:  Jaffe E,  Stein H,  Vardiman JW editor. Pathology and genetics of tumours of hematopoietic and lymphoid tissues. Lyon: IARC Press; 2001;
  21. Esteve J, Benhamou E, Raymond L. Statistical methods in cancer research. Descriptive epidemiology. vol. IV. France: International Agency for Research on Cancer; 1994;
  22. Suarez F, Lortholary O, Hermine O, Lecuit M. Infection-associated lymphomas derived from marginal zone B cells: a model of antigen-driven lymphoproliferation. Blood. 2006;107:3034–3044
  23. Perez-Perez GI, Olivares AZ, Foo FY, Foo S, Neusy AJ, Ng C, et al. Seroprevalence of Helicobacter pylori in New York City populations originating in East Asia. J Urban Health. 2005;82:510–516
  24. McQuillan GM, Kruszon-Moran D, Kottiri BJ, Curtin LR, Lucas JW, Kington RS. Racial and ethnic differences in the seroprevalence of 6 infectious diseases in the United States: data from NHANES III. 1988–1994. Am J Public Health. 2004;94:1952–1958
  25. Nguyen MH, Keeffe EB. Chronic hepatitis B and hepatitis C in Asian Americans. Rev Gastroenterol Disord. 2003;3:125–134
  26. Hwang SJ, Tong MJ, Lai PP, Ko ES, Co RL, Chien D, et al. Evaluation of hepatitis B and C viral markers: clinical significance in Asian and Caucasian patients with hepatocellular carcinoma in the United States of America. J Gastroenterol Hepatol. 1996;11:949–954
  27. Valleroy LA, MacKellar DA, Karon JM, Rosen DH, McFarland W, Shehan DA, et al. HIV prevalence and associated risks in young men who have sex with men. Young Men's Survey Study Group. JAMA. 2000;284:198–204
  28. Morales Suarez-Varela MM, Llopis Gonzalez A, Marquina Vila A, Bell J. Mycosis fungoides: review of epidemiological observations. Dermatology. 2000;201:21–28
  29. Burg G, Kempf W, Cozzio A, Feit J, Willemze RS, Jaffe E, et al. WHO/EORTC classification of cutaneous lymphomas 2005: histological and molecular aspects. J Cutan Pathol. 2005;32:647–674
  30. Ravat FE, Spittle MF, Russell-Jones R. Primary cutaneous T-cell lymphoma occurring after organ transplantation. J Am Acad Dermatol. 2006;54:668–675
  31. Perret JL, Moussavou-Kombila JB, Delaporte E, Coniquet S, Nguemby-Mbina C, Normand P. Mycosis fungoides in a Gabonese patient infected with HTLV-I. Med Trop. 1996;56:66–68
  32. McMullan DM, Radovaneevic B, Jackow CM, Frazier OH, Duvic M. Cutaneous T-cell lymphoma in a cardiac transplant recipient. Tex Heart Inst J. 2001;28:203–207
  33. Morozov VA, Syrtsev AV, Ellerbrok H, Nikolaeva EV, Bavykin AS, Pauli G. Mycosis fungoides in European Russia: no antibodies to human T cell leukemia virus type I structural proteins, but virus-like sequences in blood and saliva. Intervirology. 2005;48:362–371
  34. Morales-Suarez-Varela MM, Olsen J, Johansen P, Kaerlev L, Guénel P, Arveux P, et al. Occupational exposures and mycosis fungoides. A European multicentre case-control study (Europe). Cancer Causes Control. 2005;16:1253–1259
  35. Hirose Y, Masaki Y, Sawaki T, Shimoyama K, Karasawa H, Kawabata H, et al. Association of Epstein–Barr virus with human immunodeficiency virus-negative peripheral T-cell lymphomas in Japan. Eur J Haematol. 2006;76:109–118
  36. Anagnostopoulos I, Hummel M, Finn T, Tiemann M, Korbjuhn P, Dimmler C, et al. Heterogeneous Epstein–Barr virus infection patterns in peripheral T cell lymphoma of the angioimmunoblastic lymphadenopathy type. Verh Dtsch Ges Pathol. 1992;76:202–206
  37. Hartge P, Devesa SS, Grauman D, Fears TR, Fraumeni JF, et al. Non-Hodgkin's lymphoma and sunlight. J Natl Cancer Inst. 1996;88:298–300
  38. Besson C, Goubar A, Gabarre J, Rozenbaum W, Pialoux G, Châtelet FP, et al. Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapy. Blood. 2001;98:2339–2344
  39. Kadan-Lottick NS, Skluzacek MC, Gurney JG. Decreasing incidence rates of primary central nervous system lymphoma. Cancer. 2002;95:193–202
  40. Sepkowitz KA. AIDS—the first 20 years. N Engl J Med. 2001;344:1764–1772
  41. Shmuely H, Passaro D, Figer A, Niv Y, Pitlik S, Samra Z, et al. Relationship between Helicobacter pylori CagA status and colorectal cancer. Am J Gastroenterol. 2001;96:3406–3410
  42. Psyrri A, Papageorgiou S, Economopoulos T. Primary extranodal lymphomas of stomach: clinical presentation, diagnostic pitfalls and management. Ann Oncol. 2008;19:1992–1999
  43. Cavanna L, Pagani R, Seghini P, Zangrandi A, Paties C. High grade B-cell gastric lymphoma with complete pathologic remission after eradication of Helicobacter pylori infection: report of a case and review of the literature. World J Surg Oncol. 2008;6:35
  44. Nakamura S, Matsumoto T, Ye H, Nakamura S, Suekane H, Matsumoto H, et al. Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphoma: a clinicopathologic and molecular study with reference to antibiotic treatment. Cancer. 2006;107:2770–2778
  45. Iwano M, Watanabe N, Matsushima Y, Seno H, Oki K, Sakurai T, et al. Rapid development of diffuse large B-Cell lymphoma after successful eradication of Helicobacter pylori for gastric MALT lymphoma. Am J Gastroenterol. 2006;101:2878–2883
  46. Logsdon MD, Ha CS, Kavadi VS, Cabanillas F, Hess MA, Cox JD. Lymphoma of the nasal cavity and paranasal sinuses: improved outcome and altered prognostic factors with combined modality therapy. Cancer. 1997;80:477–488
  47. Horner M. Ries LAG, Krapcho M, Neyman N, Aminou R, Howlader N, et al., editors. SEER Cancer Statistics Review, 1975–2006. Bethesda, MD: National Cancer Institute. http://seer.cancer.gov/csr/1975_2006/ [Based on November 2008 SEER data submission, posted to the SEER web site, 2009].
  48. Zhang B, Zong Y, He J, Zhong B, Lin S. Primary nasopharyngeal non-Hodgkin lymphoma and its relationship with Epstein–Barr virus infection. Chin Med J. 2003;116:913–917
  49. Chien YC, Chen JY, Liu MY, Yang HI, Hsu MM, Chen CJ, et al. Serologic markers of Epstein–Barr virus infection and nasopharyngeal carcinoma in Taiwanese men. N Engl J Med. 2001;345:1877–1882
  50. Hsu WL, Chen JY, Chien YC, Liu MY, You SL, Hsu MM, et al. Independent effect of EBV and cigarette smoking on nasopharyngeal carcinoma: a 20-year follow-up study on 9,622 males without family history in Taiwan. Cancer Epidemiol Biomarkers Prev. 2009;18:1218–1226
  51. Olson JE, Janney CA, Rao RD, Cerhan JR, Kurtin PJ, Schiff D, et al. The continuing increase in the incidence of primary central nervous system non-Hodgkin lymphoma: a surveillance, epidemiology, and end results analysis. Cancer. 2002;95:1504–1510
  52. Moslehi R, Devesa SS, Schairer C, Fraumeni JF. Rapidly increasing incidence of ocular non-hodgkin lymphoma. J Natl Cancer Inst. 2006;98:936–939
  53. Ferreri AJ, Dolcetti R, Du MQ, Doglioni C, Resti AG, Politi LS, et al. Ocular adnexal MALT lymphoma: an intriguing model for antigen-driven lymphomagenesis and microbial-targeted therapy. Ann Oncol. 2008;19:835–846
  54. Ponzoni M, Ferreri AJ, Guidoboni M, Lettini AA, Cangi MG, Pasini E, et al. Chlamydia infection and lymphomas: association beyond ocular adnexal lymphomas highlighted by multiple detection methods. Clin Cancer Res. 2008;14:5794–5800
  55. Clarke CA, Glaser SL. Changing incidence of non-Hodgkin lymphomas in the United States. Cancer. 2002;94:2015–2023

PII: S1877-7821(09)00125-8

doi: 10.1016/j.canep.2009.09.006

Cancer Epidemiology
Volume 33, Issue 5 , Pages 337-346 , November 2009

Article Tools

* Image Usage & Resolution